Document is current
Any future updates will be listed below
-
Authors
Allott, Emma H. https://orcid.org/0000-0003-1227-3615
Shan, Yue
Chen, Mengjie
Sun, Xuezheng
Garcia-Recio, Susana
Kirk, Erin L.
Olshan, Andrew F.
Geradts, Joseph
Earp, H. Shelton
Carey, Lisa A.
Perou, Charles M.
Pfeiffer, Ruth M.
Anderson, William F.
Troester, Melissa A.
-
Funding
Funding for this research was provided by:
National Cancer Institute (U01-CA179715, P50-CA058223)
Susan G. Komen
American Institute for Cancer Research
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
- License Information
-
More Information
Article History
Received: 9 July 2019
Accepted: 10 September 2019
First Online: 18 September 2019
Compliance with ethical standards
:
: C. M. Perou is a consultant, an equity stock holder and Board of Director Member of BioClassifier LLC. C. M. Perou is also listed as an inventor on a patent application on the PAM50 molecular assay. H. S. Earp is a consultant and a stock holder for Meryx. The other authors declare that they have no competing interests.
: The study was approved by the Office of Human Research Ethics at the University of North Carolina at Chapel Hill (UNC).
: Informed consent was obtained from each participant.
